Posaconazole Tablet, Delayed Release
Product Images NDC 16714-535

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 16714-535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Posaconazole-container-label (Posaconazole Container Label)

Each delayed-release tablet contains 100 mg of posaconazole - NDC 1671453501. Posaconazole should be stored at 20° to 25°C (68° to 77°F), and excursions permitted to 15° to 30°C (59° to 86°F). Noxafill®oral suspension and Posaconazole delayed-release tablets are not interchangeable due to differences in the dosing of each formulation. The usual dosage should be seen in the package insert. The tablets are manufactured for Northstar Rx LLC. Hetero Labs Limited is the manufacturer and the product of India. Further details are not-available.*

FDA Label Image

Posaconazole-structure (Posaconazole Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.